Src Inhibitor 1 2X5mg

Alternative_Names

Src Kinase Inhibitor 1;Src-l1
CAS

179248-59-0
Purity

>98%
MWt

373.40
Formula

C22H19N3O3
Solubility

DMSO : 6.2 mg/mL (16.60 mM; Need ultrasonic)
Clinical_Information

No Development Reported
Pathway

Protein Tyrosine Kinase/RTK
Target

Src
Description

Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.

Gene target

Src Inhibitor 2X5mg
Short name

Src Inhibitor 1 2X5mg
Alternative name

v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) suppressor 1 2X5mg
Alternative to gene target

v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian), ASV and c-SRC and p60-Src and SRC1, SRC and IDBG-74081 and ENSG00000197122 and 6714, transferase activity, nuclei, Src and IDBG-211273 and ENSMUSG00000027646 and 20779, BT.61976 and IDBG-642561 and ENSBTAG00000008938 and 535742